PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New avenue to treat diabetes-related vision problems

Eye on dopamine

2014-01-22
(Press-News.org) Contact information: Quinn Eastman
qeastma@emory.edu
404-727-7829
Emory Health Sciences
New avenue to treat diabetes-related vision problems Eye on dopamine Dopamine-restoring drugs already used to treat Parkinson's disease may also be beneficial for the treatment of diabetic retinopathy, a leading cause of blindness in adults, researchers have discovered.

The results were published in the Jan. 15 issue of Journal of Neuroscience.

Diabetic retinopathy affects more than a quarter of adults with diabetes and threatening the vision of more than 600,000 people in the United States.

Doctors had previously thought most of the impairment of vision in diabetic retinopathy came from damage to the blood vessels induced by high blood sugar, but had known that dopamine, a vital neurotransmitter in the brain, was also important in the retina.

"There was some evidence already that dopamine levels were reduced in diabetic retinopathy, but what's new here is: we can restore dopamine levels and improve visual function in an animal model of diabetes," says Machelle Pardue, PhD, associate professor of ophthalmology at Emory University School of Medicine and research career scientist at the Atlanta VA Medical Center.

The first author of the paper is MD/PhD student Moe Aung. Senior authors are Pardue and P. Michael Iuvone, PhD, professor of ophthalmology and pharmacology and director of vision research at Emory Eye Center.

Aung and his colleagues examined mice that were made diabetic by treating them with streptozocin, which is toxic to insulin-producing cells in the pancreas. By injecting the mice with L-DOPA after getting streptozocin, the researchers could delay the appearance of visual problems by weeks and lessen the severity of the visual defects. Researchers also found that the visual benefits of L-DOPA originated from the retinas, since treatment improved retinal responses (as measured by electroretinography) to levels similar to control animals.

Vision was assessed by putting mice on a platform and measuring whether they moved their heads in response to a rotating pattern of vertical lines projected on a cylinder around the mouse. The fineness and contrast of the lines can be modulated to test the mouse's vision.

L-DOPA, a precursor to dopamine, is part of the most common drug treatment for Parkinson's disease. The symptoms of Parkinson's (tremors and movement difficulties, as well as disturbances in sleep, digestion and cognition) are caused by the death of dopamine-producing cells in the brain. L-DOPA is usually combined with carbidopa to combat side effects and increase uptake in the brain.

The researchers also measured the effects of other dopamine-related treatments on visual function. Dopamine receptor agonists – drugs that mimic the action of dopamine – are sometimes prescribed for Parkinson's patients who do not respond to L-DOPA. Neurons and retinal cells have several molecules that enable them to respond to dopamine, and individual drugs affect them to varying degrees. Working with Iuvone, MSP graduate student Chad Jackson, now at Vanderbilt, found that giving diabetic mice dopamine receptor agonists that acted on the receptor D1R improved the ability to see fine lines (acuity), while drugs that act on D4R improve contrast sensitivity.

"This is important because it shows that treatments targeting dopamine could be beneficial to patients with established diabetes," says Iuvone. "It should be straightforward to try L-DOPA or dopamine receptor agonist treatment in adults, although L-DOPA could have complications in children. Bromocriptine, a dopamine receptor agonist, is already FDA-approved to treat type 2 diabetes. It will be important to determine if the same dopamine receptors modulate acuity and contrast sensitivity in humans."

### This work was supported by the National Eye Institute (P30 EY006360 and R01 EY004864), the National Institute of Diabetes and Digestive and Kidney Diseases (DK07601-01), the Department of Veterans Affairs, Research to Prevent Blindness, the Juvenile Diabetes Research Foundation and Children's Healthcare of Atlanta.


ELSE PRESS RELEASES FROM THIS DATE:

No-till soybean fields give (even some rare) birds a foothold in Illinois

2014-01-22
No-till soybean fields give (even some rare) birds a foothold in Illinois CHAMPAIGN, Ill. — Researchers report in a new study that several bird species – some of them relatively rare – are making extensive use of soybean fields in Illinois. The team ...

Live feed into our bodies

2014-01-22
Live feed into our bodies A palm-top device developed by UCSB researchers provides real-time insight into how fast a living body metabolizes drugs, opening the door to highly personalized medicine (Santa Barbara, Calif.) — A device that ...

Sedentary behavior and low physical activity linked to heart failure in men

2014-01-22
Sedentary behavior and low physical activity linked to heart failure in men PASADENA, CALIF., 21, 2014 — Men who reported being sedentary with low levels of physical activity were at a significantly higher risk for heart failure than those who were more active, ...

Cancer diagnosis doesn't increase a child's risk of post-traumatic stress disorder

2014-01-22
Cancer diagnosis doesn't increase a child's risk of post-traumatic stress disorder A St. Jude Children's Research Hospital study found that despite being diagnosed with life-threatening illnesses, childhood cancer patients are no more likely than ...

Subterranean 'sedimentary bathtub' amplifies earthquakes

2014-01-22
Subterranean 'sedimentary bathtub' amplifies earthquakes A basin of stiff soil beneath Vancouver might make earthquakes there more severe than expected, a San Diego State University seismologist finds SAN DIEGO, Calif. (Jan. 21, 2014)— Like an amphitheater amplifies ...

Emergency treatment takes longer for heart attack victims during off-hours

2014-01-22
Emergency treatment takes longer for heart attack victims during off-hours ROCHESTER, Minn. — Jan. 21, 2014 — More people die and emergency hospital treatment takes longer for heart attack victims who arrive at the hospital during off-hours (nights and weekends), compared ...

White, green or black roofs? Berkeley Lab report compares economic payoffs

2014-01-22
White, green or black roofs? Berkeley Lab report compares economic payoffs Looking strictly at the economic costs and benefits of three different roof types—black, white and "green" (or vegetated)—Lawrence Berkeley National Laboratory (Berkeley Lab) ...

Exposure to cold temperatures can help boost weight loss

2014-01-22
Exposure to cold temperatures can help boost weight loss Regular exposure to mild cold may be a healthy and sustainable way to help people lose weight, according to researchers writing in the Cell Press publication Trends in Endocrinology & Metabolism on January 22nd. On ...

Parental exposure to THC Linked to drug addiction, compulsive behavior in unexposed offspring

2014-01-22
Parental exposure to THC Linked to drug addiction, compulsive behavior in unexposed offspring Mount Sinai study pinpoints molecular and neurobiological effects of THC, the main psychoactive ingredient in marijuana New York, NY ...

Sneak preview of Survey Telescope treasure trove

2014-01-22
Sneak preview of Survey Telescope treasure trove VST images the Lagoon Nebula The VLT Survey Telescope (VST) at ESO's Paranal Observatory in Chile has captured this richly detailed new image of the Lagoon Nebula. This giant cloud of gas and dust is creating intensely bright young stars, ...

LAST 30 PRESS RELEASES:

New strategies to enhance chiral optical signals unveiled

Cambridge research uncovers powerful virtual reality treatment for speech anxiety

2025 Gut Microbiota for Health World Summit to spotlight groundbreaking research

International survey finds that support for climate interventions is tied to being hopeful and worried about climate change

Cambridge scientist launches free VR platform that eliminates the fear of public speaking

Open-Source AI matches top proprietary model in solving tough medical cases

Good fences make good neighbors (with carnivores)

NRG Oncology trial supports radiotherapy alone following radical hysterectomy should remain the standard of care for early-stage, intermediate-risk cervical cancer

Introducing our new cohort of AGA Future Leaders

Sharks are dying at alarming rates, mostly due to fishing. Retention bans may help

Engineering excellence: Engineers with ONR ties elected to renowned scientific academy

New CRISPR-based diagnostic test detects pathogens in blood without amplification

Immunotherapy may boost KRAS-targeted therapy in pancreatic cancer

Growing solar: Optimizing agrivoltaic systems for crops and clean energy

Scientists discover how to reactivate cancer’s molecular “kill switch”

YouTube influencers: gaming’s best friend or worst enemy?

uOttawa scientists use light to unlock secret of atoms

NJIT mathematician to help map Earth's last frontier with Navy grant

NASA atmospheric wave-studying mission releases data from first 3,000 orbits

‘Microlightning’ in water droplets may have sparked life on Earth

Smoke from wildland-urban interface fires more deadly than remote wildfires

What’s your body really worth? New AI model reveals your true biological age from 5 drops of blood

Protein accidentally lassos itself, helping explain unusual refolding behavior

With bird flu in raw milk, many in U.S. still do not know risks of consuming it

University of Minnesota research team awarded $3.8 million grant to develop cell therapy to combat Alzheimer’s disease

UConn uncovers new clue on what is leading to neurodegenerative diseases like Alzheimer’s and ALS

Resuscitation in out-of-hospital cardiac arrest – it’s how quickly it is done, rather than who does it

A closer look at biomolecular ‘silly putty’

Oxytocin system of breastfeeding affected in mothers with postnatal depression

Liquid metal-enabled synergetic cooling and charging: a leap forward for electric vehicles

[Press-News.org] New avenue to treat diabetes-related vision problems
Eye on dopamine